Lumican-null mice are susceptible to aging and isoproterenol-induced myocardial fibrosis.

[1]  C. B. Kern,et al.  Lumican deficiency results in cardiomyocyte hypertrophy with altered collagen assembly. , 2015, Journal of molecular and cellular cardiology.

[2]  Biljana Skrbic,et al.  Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli , 2013, The FEBS journal.

[3]  Mounir Errami,et al.  Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure , 2009, BMC Physiology.

[4]  C. H. Conrad,et al.  Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates. , 2009, Comparative medicine.

[5]  P. Schauerte,et al.  Age-related atrial fibrosis , 2009, AGE.

[6]  P. Lijnen,et al.  Early expression of monocyte chemoattractant protein-1 correlates with the onset of isoproterenol-induced cardiac fibrosis in rats with distinct angiotensin-converting enzyme polymorphism , 2008, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[7]  D. Laude,et al.  Accelerated arterial stiffening and gene expression profile of the aorta in patients with coronary artery disease , 2008, Journal of hypertension.

[8]  S. Lipshultz,et al.  Isoproterenol-induced Cardiotoxicity in Sprague-Dawley Rats: Correlation of Reversible and Irreversible Myocardial Injury with Release of Cardiac Troponin T and Roles of iNOS in Myocardial Injury , 2008, Toxicologic pathology.

[9]  Francis G Spinale,et al.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. , 2007, Physiological reviews.

[10]  M. Ashraf,et al.  Small Heat-Shock Protein Hsp20 Attenuates &bgr;-Agonist–Mediated Cardiac Remodeling Through Apoptosis Signal–Regulating Kinase 1 , 2006, Circulation research.

[11]  Ronen Beeri,et al.  Transcription factor MITF regulates cardiac growth and hypertrophy. , 2006, The Journal of clinical investigation.

[12]  J. S. Janicki,et al.  The relationship between myocardial extracellular matrix remodeling and ventricular function. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[13]  R. Sheppard,et al.  Fibrosis in heart disease: understanding the role of transforming growth factor‐β1 in cardiomyopathy, valvular disease and arrhythmia , 2006, Immunology.

[14]  Marian F Young,et al.  The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. , 2005, The Journal of clinical investigation.

[15]  Ryan T. Strachan,et al.  Strain-dependent beta-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice. , 2005, American journal of physiology. Heart and circulatory physiology.

[16]  Z. Naito.  Role of the small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth. , 2005, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[17]  C. Molina,et al.  Functional Role of Phosphodiesterase 3 in Cardiomyocyte Apoptosis: Implication in Heart Failure , 2005, Circulation.

[18]  S. Oparil,et al.  Atrial Natriuretic Peptide Dose-Dependently Inhibits Pressure Overload–Induced Cardiac Remodeling , 2004, Hypertension.

[19]  Munirah Ahmad,et al.  Cleavage of Lumican by Membrane-Type Matrix Metalloproteinase-1 Abrogates This Proteoglycan-Mediated Suppression of Tumor Cell Colony Formation in Soft Agar , 2004, Cancer Research.

[20]  N. Vij,et al.  Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea. , 2004, Experimental eye research.

[21]  U. Eriksson,et al.  Phosphoinositide 3-Kinase &ggr;–Deficient Mice Are Protected From Isoproterenol-Induced Heart Failure , 2003 .

[22]  Dajun Wang,et al.  Effects of Pressure Overload on Extracellular Matrix Expression in the Heart of the Atrial Natriuretic Peptide–Null Mouse , 2003, Hypertension.

[23]  C. Delcayre,et al.  Molecular mechanisms of myocardial remodeling. The role of aldosterone. , 2002, Journal of molecular and cellular cardiology.

[24]  George C Tseng,et al.  Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. , 2002, Physiological genomics.

[25]  W. Colucci,et al.  Interleukin-1β and Tumor Necrosis Factor-α Decrease Collagen Synthesis and Increase Matrix Metalloproteinase Activity in Cardiac Fibroblasts In Vitro , 2000 .

[26]  S. Saika,et al.  Role of Lumican in the Corneal Epithelium during Wound Healing* , 2000, The Journal of Biological Chemistry.

[27]  I. Benjamin,et al.  Isoproterenol-Induced Myocardial Fibrosis in Relation to Myocyte Necrosis , 1989, Circulation research.

[28]  J. S. Janicki,et al.  The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat. , 1989, The American journal of pathology.

[29]  P. Roughley,et al.  Lumican is down-regulated in cells expressing endoglin. Evidence for an inverse correlationship between Endoglin and Lumican expression. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[30]  B. Hoit,et al.  Compensated hypertrophy of cardiac ventricles in aged transgenic FVB/N mice overexpressing calsequestrin , 2004, Molecular and Cellular Biochemistry.

[31]  B. Swynghedauw,et al.  Molecular mechanisms of myocardial remodeling. , 1999, Physiological reviews.